- Filed
- Mar 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Mar 17, 2026 | 53.14M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 53.14M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2025 | 61.76M sh |
| Operating Cash Flow | Q1 2026 · Jan 31, 2026 | −$42.64K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2025 | $157.27K |
| Stockholders Equity | Q1 2026 · Jan 31, 2026 | $868.84K |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | $1.03M |
| Stockholders Equity | Q1 2026 · Jan 31, 2025 | $1.14M |
| Stockholders Equity | Q1 2026 · Oct 31, 2024 | $889.53K |
| Current Liabilities | Q1 2026 · Jan 31, 2026 | $912.1K |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $803.3K |
| Total Liabilities | Q1 2026 · Jan 31, 2026 | $912.1K |
| Total Liabilities | Q1 2026 · Oct 31, 2025 | $803.3K |
| Current Assets | Q1 2026 · Jan 31, 2026 | $1.78M |
| Current Assets | Q1 2026 · Oct 31, 2025 | $1.83M |
| Total Assets | Q1 2026 · Jan 31, 2026 | $1.78M |
| Total Assets | Q1 2026 · Oct 31, 2025 | $1.83M |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Jan 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Jan 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Jan 31, 2026 | $273.13K |
| Sga Expense restated | Q1 2026 · Jan 31, 2025 | $196.74K |
| Net Income | Q1 2026 · Jan 31, 2026 | −$226.51K |
| Net Income | Q1 2026 · Jan 31, 2025 | $229.06K |
| Operating Income | Q1 2026 · Jan 31, 2026 | −$217.22K |
| Operating Income | Q1 2026 · Jan 31, 2025 | $198.24K |
| Revenue | Q1 2026 · Jan 31, 2026 | $549.39K |
| Revenue | Q1 2026 · Jan 31, 2025 | $828.05K |